Cytomab 100mg Injection

About

Cytomab 100mg Injection contains rituximab, a chimeric monoclonal antibody designed to selectively target the CD20 antigen, a transmembrane protein found on the surface of pre-B and mature B-lymphocytes. Its mechanism of action involves binding to CD20, which subsequently triggers various immune effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of apoptosis. This leads to the depletion of CD20-positive B cells, making it an effective therapeutic agent for a range of B-cell malignancies, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

It is also used in certain autoimmune diseases like rheumatoid arthritis and vasculitis, where B cells contribute to disease pathogenesis. By selectively removing these cells, rituximab helps to control disease progression and alleviate symptoms, offering a targeted approach to immune modulation.

Uses

• Treatment of non-Hodgkin's lymphoma (NHL).
• Treatment of chronic lymphocytic leukemia (CLL).
• Treatment of rheumatoid arthritis (RA) in combination with methotrexate.
• Treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

Directions For Use

Administered as an intravenous infusion by a healthcare professional. Pre-medication is often required to reduce infusion-related reactions.

Benefits

• Induces significant B-cell depletion, leading to disease control.
• Effective in combination with chemotherapy for various cancers.
• Reduces inflammation and joint damage in rheumatoid arthritis.
• Provides long-lasting remission in certain autoimmune conditions.
• Well-tolerated by many patients with appropriate pre-medication.
• Offers a targeted approach to immune modulation.

Side Effects

• Infusion-related reactions (fever, chills, rash)
• Increased risk of infections
• Progressive multifocal leukoencephalopathy (PML)
• Hepatitis B reactivation
• Neutropenia
• Thrombocytopenia
• Anemia
• Hypotension
• Headache
• Nausea
• Fatigue
• Pruritus

Safety Measures

• Alcohol - No specific contraindication with alcohol, but patients should consult their doctor, especially if they have underlying liver conditions or are on other medications.
• Pregnancy - Contraindicated during pregnancy due to potential B-cell depletion in the fetus; women of childbearing potential must use effective contraception during and for 12 months post-treatment.
• Breastfeeding - Not recommended for breastfeeding mothers as rituximab can be excreted in breast milk and may cause adverse effects in the infant.
• Liver - Patients with a history of hepatitis B must be screened and monitored closely due to the risk of viral reactivation; prophylactic antiviral therapy may be necessary.
• Kidney - No dose adjustment is typically required for renal impairment, but caution and monitoring are advised in severe cases.
• Lung - Caution is advised in patients with pre-existing pulmonary conditions, as rituximab can rarely cause severe pulmonary events, including interstitial lung disease.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.